Cargando…

Clinical significance of circulating tumour cells and tumour marker detection in the chemotherapeutic evaluation of advanced colorectal cancer

AIM: Systemic chemotherapy combining biological targeted therapies is the standard therapy for patients with metastatic colorectal cancer (mCRC), but effective markers are needed to identify clinical responders. Circulating tumour cells (CTCs) have been associated with prognosis in patients with mCR...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shen, Feifei, Zhu, Yiwen, Wang, Fan, Cai, Xun, Ding, Honghua, Zhou, Fei, Wang, Jingjue, Gu, Hongli, Liu, Chuan, Li, Qi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9298334/ https://www.ncbi.nlm.nih.gov/pubmed/34611964 http://dx.doi.org/10.1111/codi.15939

Ejemplares similares

Significant diagnostic value of circulating tumour cells in colorectal cancer
por: Yu, Haijiao, et al.
Publicado: (2020)

Wilms’ tumour and chemotherapeutic access
por: Yasri, Sora, et al.
Publicado: (2015)

Tumour suppressor genes in chemotherapeutic drug response
por: Lai, Dulcie, et al.
Publicado: (2012)

Molecular markers in circulating tumour cells from metastatic colorectal cancer patients
por: Gazzaniga, Paola, et al.
Publicado: (2010)

Clinical significance of CDX2-positive circulating tumour cells in colorectal cancer patients
por: Wong, S C C, et al.
Publicado: (2011)

Co-expression of Lgr5 and CXCR4 characterizes cancer stem-like cells of colorectal cancer
por: Wu, Weidong, et al.
Publicado: (2016)

Tumour markers of prognosis in colorectal cancer
por: McLeod, H L, et al.
Publicado: (1999)

Circulating tumour DNA in colorectal cancer management
por: Cohen, Ryan, et al.
Publicado: (2023)

Tumour-Associated Transcripts and EGFR Deletion Variants in Colorectal Cancer in Primary Tumour, Metastases and Circulating Tumour Cells
por: Lankiewicz, Silke, et al.
Publicado: (2008)

In vitro sensitivity of human ovarian tumours to chemotherapeutic agents.
por: Wilson, A. P., et al.
Publicado: (1981)

Circulating tumour-derived nucleic acids in cancer patients: potential applications as tumour markers
por: Chan, K C A, et al.
Publicado: (2007)

Circulating Tumour Cells, Circulating Tumour DNA and Circulating Tumour miRNA in Blood Assays in the Different Steps of Colorectal Cancer Management, a Review of the Evidence in 2019
por: Christou, Niki, et al.
Publicado: (2019)

Prognostic significance of circulating tumour cells following surgical resection of colorectal cancers: a systematic review
por: Peach, G, et al.
Publicado: (2010)

Immunological and prognostic significance of tumour necrosis in colorectal cancer
por: Kastinen, Meeri, et al.
Publicado: (2023)

Circulating tumour cells and tumour biomarkers in functional midgut neuroendocrine tumours
por: Meyer, Tim, et al.
Publicado: (2022)

Direct comparison study of DNA methylation markers in EpCAM-positive circulating tumour cells, corresponding circulating tumour DNA, and paired primary tumours in breast cancer
por: Chimonidou, Maria, et al.
Publicado: (2017)

Genetic Heterogeneity of Single Circulating Tumour Cells in Colorectal Carcinoma
por: Hamid, Faysal Bin, et al.
Publicado: (2020)

International scientific communications in the field of colorectal tumour markers
por: Ivanov, Krasimir, et al.
Publicado: (2017)

MicroRNA-17-5p promotes chemotherapeutic drug resistance and tumour metastasis of colorectal cancer by repressing PTEN expression
por: Fang, Lekun, et al.
Publicado: (2014)

The Sensitivity to Chemotherapeutic Agents of a Rat Tumour Grown in Immunosuppressed Mice
por: Sheard, Christine E., et al.
Publicado: (1971)

Analysis of Circulating Tumour Cells in Early-Stage Uveal Melanoma: Evaluation of Tumour Marker Expression to Increase Capture
por: Beasley, Aaron B., et al.
Publicado: (2021)

Individualised multiplexed circulating tumour DNA assays for monitoring of tumour presence in patients after colorectal cancer surgery
por: Ng, Sarah B., et al.
Publicado: (2017)

Breast Tumour Kinase (Brk/PTK6) Contributes to Breast Tumour Xenograft Growth and Modulates Chemotherapeutic Responses In Vitro
por: Burmi, Rajpal S., et al.
Publicado: (2022)

Diagnostic value of CA19.9, circulating tumour DNA and circulating tumour cells in patients with solid pancreatic tumours
por: Sefrioui, David, et al.
Publicado: (2017)

Serum levels of IL-6 and CRP can predict the efficacy of mFOLFIRINOX in patients with advanced pancreatic cancer
por: Shen, Feifei, et al.
Publicado: (2022)

Comparison of four serum tumour markers in the diagnosis of colorectal carcinoma.
por: van der Schouw, Y. T., et al.
Publicado: (1992)

A model of quiescent tumour microregions for evaluating multicellular resistance to chemotherapeutic drugs
por: Mellor, H R, et al.
Publicado: (2005)

The distribution of the apparent diffusion coefficient as an indicator of the response to chemotherapeutics in ovarian tumour xenografts
por: Tourell, Monique C., et al.
Publicado: (2017)

Clinical significance of circulating tumour cells and Ki-67 in renal cell carcinoma
por: Song, Jinbo, et al.
Publicado: (2021)

Identification of mutation patterns and circulating tumour DNA-derived prognostic markers in advanced breast cancer patients
por: Liao, Hao, et al.
Publicado: (2022)

Presence and significance of tumour cells in the spleen of tumour-bearing hamsters.
por: Zuinghedau, J., et al.
Publicado: (1979)

Colorectal Tumour Mucosa Microbiome Is Enriched in Oral Pathogens and Defines Three Subtypes That Correlate with Markers of Tumour Progression
por: Zwinsová, Barbora, et al.
Publicado: (2021)

Reconsidering the prognostic significance of tumour deposit count in the TNM staging system for colorectal cancer
por: Wang, Song, et al.
Publicado: (2020)

Prognostic significance of pre- and post-operative tumour markers for patients with gastric cancer
por: Lin, Jun-Peng, et al.
Publicado: (2020)

Assessing tumour markers.
por: Tate, H.
Publicado: (1981)

Integrated analysis of circulating tumour cells and circulating tumour DNA to detect minimal residual disease in hepatocellular carcinoma
por: Zhao, Lina, et al.
Publicado: (2022)

The Value of Haematological Parameters and Tumour Markers in the Prediction of Intestinal Obstruction in 1474 Chinese Colorectal Cancer Patients
por: Cao, Yinghao, et al.
Publicado: (2020)

Circulating tumour cells and their association with bone metastases in patients with neuroendocrine tumours
por: Rizzo, Francesca M., et al.
Publicado: (2019)

The Significance of Studies with Transplanted Tumours
por: Gorer, P. A.
Publicado: (1948)

Plasma Epstein–Barr virus DNA as an archetypal circulating tumour DNA marker
por: Lam, Wai Kei Jacky, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_qcjd9hu0k8e4spk2bh3qom2i4i